National Research Co. (NASDAQ:NRC) Shares Acquired by Barclays PLC

Barclays PLC raised its position in National Research Co. (NASDAQ:NRC) by 65.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 51,331 shares of the company’s stock after purchasing an additional 20,331 shares during the quarter. Barclays PLC’s holdings in National Research were worth $1,175,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Millennium Management LLC lifted its position in National Research by 200.9% during the second quarter. Millennium Management LLC now owns 214,858 shares of the company’s stock valued at $4,931,000 after buying an additional 143,454 shares in the last quarter. Hotchkis & Wiley Capital Management LLC acquired a new position in shares of National Research during the third quarter worth about $3,158,000. Marshall Wace LLP acquired a new stake in shares of National Research in the second quarter valued at about $1,644,000. Renaissance Technologies LLC grew its position in National Research by 14.4% in the second quarter. Renaissance Technologies LLC now owns 432,884 shares of the company’s stock valued at $9,935,000 after acquiring an additional 54,600 shares in the last quarter. Finally, Algert Global LLC lifted its position in shares of National Research by 94.0% during the third quarter. Algert Global LLC now owns 82,921 shares of the company’s stock worth $1,896,000 after purchasing an additional 40,182 shares in the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Stock Up 2.9 %

Shares of National Research stock opened at $17.27 on Tuesday. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. National Research Co. has a 1-year low of $16.56 and a 1-year high of $42.00. The business has a 50-day moving average of $18.62 and a 200-day moving average of $20.62. The company has a market capitalization of $405.43 million, a PE ratio of 15.28 and a beta of 0.53.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Friday, October 25th. The company reported $0.24 earnings per share (EPS) for the quarter. The company had revenue of $35.82 million for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%.

National Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.78%. The ex-dividend date was Friday, December 27th. National Research’s dividend payout ratio is currently 42.48%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.